We plan to Examine Medical Interventions for Paedophilia to reduce the risk of Child Sexual Abuse


Campaign Complete. This project has ended on July 7, 2016. No more contributions can be made.

  • £2,493.00

    Pledged of £38,000.00 Goal

  • 76

    Backers

  • 0

    Hours to Go

All funds will be collected by July 7, 2016.

Share this campaign

Help raise awareness for this campaign by sharing this widget. Simply paste the following HTML code most places on the web.

Embed Code

<iframe src="https://crowd.science/campaigns/priotab-to-treat-paedophilia/?widget=1" width="260px" height="500px" frameborder="0" scrolling="no" /></iframe>

THE KAROLINSKA INSTITUTE

WE ARE RAISING £38k* TOWARDS A RANDOMISED CONTROL TRIAL THAT HAS ETHICAL APPROVAL TO TEST PREVENTATIVE TREATMENTS FOR PAEDOPHILIC DISORDER

*The amount of money that one case of child sexual abuse costs is approx £37k, we believe that through better medical interventions we can prevent many cases of child sexual abuse which are both tragic and costly. Please support this important research generously by pledging financially and spreading the word.  

1 in 10 girls and 1 in 20 boys

Why this study?

Child sexual abuse is hard to deal with but we must, because it affects many of us. Around 1 in 10 girls and 1 in 20 boys are abused during childhood. A substantial part of perpetrators are men with paedophilic disorder. Not all persons with paedophilia act out their sexual attraction to children, but some do.

Up until now, most of the attention has been on how to deal with perpetrators once they have been detected. But by this stage, children have already been harmed and the perpetrator has to face a future with legal consequenses that risks to ruin their life as well as the victims. With this research project we shift the focus, and explore methods of preventing child sexual abuse from happening in the first place.

The study is designed so that the results are applicable not only to the patients in the study, but also other patients, in Sweden and internationally.

Which methods are explored?

Sixty adult men with paedophilic disorder seeking help at the Centre for Andrology and Sexual Medicine, Karolinska University Hospital, Stockholm, Sweden, are to be recruited to participate in two different studies.

Firstly, a clinical trial. We plan to test a new pharmaceutical we believe has a promising profile to reduce the risk of patients committing child sexual abuse. The effects are transient and the aim is to find an acute treatment to be effective while more long term treatment strategies are organised and in addition that can be used during periods when the patients are particularly at risk of offending.

Secondly, we aim to find objective markers reflecting the risk of committing child sexual abuse, to help clinicians in situations when the interview based risk assessment is complicated or deemed unreliable. In parallel to these two studies, we also plan to analyze ethical dilemmas associated with this field of research. The overall aim is to establish an evidence based, effective and tolerable treatment programme for men seeking help for paedophilic disorder. A high priority goal in such a treatment program is preventing child sexual abuse.

Intervening on a voluntary basis with these patients before the damage is done, and offering a humane and effective, tolerable treatment, is one of only few feasible strategies to reduce the incidence of child sexual abuse and all the terror it brings about.

Who would want to participate in this study?

What is relatively unknown by the public is that a substantial number of patients with paedophilic disorder actually want help. They are very well aware of the fact that what they feel, is not accepted by the society, and that their paedophilic disorder can cause themselves many negative consequences.

Often they have the same intention as the doctor – to initiate treatment that prevent them from acting out on theirimpulses. When that risk is under control then also other treatment needs should be addressed. The person seeking help is often in crisis, can be depressed, has often suffered many years in silence before they decide to step forward and seek help. They also need someone to talk to about how to deal with the future and how to find ways of living a quality life.

Any morally based reluctance to prevent treatment for these patients, needs to be challenged – from a societal and a child perspective because it risks being counterproductive and from a patients perspective because there is often a lot of suffering associated with having paedophilic disorder.

Preventell.se is a proof of this principle. It is a national helpline for sexual problems, linked to the Center for Andrologyand Sexual Medicine at Karolinska University Hospital, Stockholm Sweden. Around 100 persons a year call Preventell.sebecause of their sexual attraction to children. Preventell.se is an important part of the recruitment basis for this study.

Aren’t there already methods to help these patients?

There are no evidence based preventive and tolerable treatments available. This is especially relevant for the acute phase. Given how prevalent the issue of child sexual abuse in our society is, it is surprising that we haven’t come further than this. There is an urgent need for more research to be done.

Although we believe other treatment methods, such as psychotherapy and social interventions, have a place in the treatment, for methodological reasons one treatment needs to be tested at a time. When we know how to measure the different risk factors and what risk factors different treatments address, we can aim at tailoring the treatment for the individual patient.

What is the rationale for testing this medicine?

The medicine, degarelix, is a third generation anti androgen pharmaceutical. It has a new mode of action and an immediate onset of effect: in only three days following the injection, 97% of the men have no detectable levels of testosterone left in the blood, and in contrast to many other anti androgens there is no initial flare of testosterone. The hypothesis that we are testing is that this medicine has a clinically significant risk reducing effect that can be noticed within 2 weeks, and which can last for up to 3 months.

What support is currently available?

There is a helpline called Preventell in Sweden and StopSo in the UK, which provides confidential support to people with paedophilia and can advice them on the treatments they can have.

Currently, the treatments available to paedophiles who seek help include counselling and some drug interventions. The drug interventions that are prescribed based on the theory that they suppress labido, however there have currently been no clinical trials testing the effectiveness of drugs in the treatment of paedophilia. If the results of this clinical trial that we are crowdfunding for are positive we will be a step closer to offering drug interventions that could help paedophiles have better control in a regulated way.

The Team

Dr Christoffer Ramm

christoffer_profilbild

Dr Christoffer Rahm is the initiator and the principal investigator of this treatment study. He did his thesis in 2013 on neuropsychological aspects on psychosis. He has then been at the University of Melbourne, Australia, for an international post doc study period, and since July 2015 he has an appointment as a post doctoral researcher at the Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden. He also works as a consultant psychiatrist at the Psykiatri Sydväst Clinic in Stockholm where he is the head of the resident doctors.

The idea about this project rose when Dr Rahm worked at CASM in 2013 and was struck by the lack of well researched treatment alternatives for the group of patients that seek help for sexual orientation for children. In collaboration with other experts, not least Ass Prof Stefan Arver, leader of the research group, Dr Rahm has designed and launched this project.

Benny Liberg

liberg

Benny Liberg, MD, PhD. Counsultant psychiatrist and researcher at the Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet. My expertise pertains to neuropsychiatry and brain imaging. The collaboration with Priotab aims at identifying brain imaging biomarkers for trigger patterns of paedophilia and the risk of commiting acts of abuse

Assistant Prof Stefan Arver

Stefan-Arver_profil_web

Stefan is director for the Centre for Andrology and Sexual Medicine Karolinska Hospital and associate professor and research group leader at Karolinska Institute. He is an endocrinologist andrologist with a focus on androgens and hormone modulating therapies and how they affect sexual function, dysfunction and dysfunctional sexuality.

Stefan says “Most sexual abuse and sexual assult are perfomed by unknown perpertrators i.e. not known to society, not known by the police or social institutions. This is the case in more than 90% of sexual  assults. Thus in order to prevent sexual offence we need to find persons at risk of committing sexual offences and enrol them in treatment programs.

The Swedish help-line project Preventell  linked to a treatment program has clearly demonstrated that individuals with risk behavior on the way to developing out of control sexual behaviour are sometimes motivated to seek help.  Therefore the research at the Karolinska Institute is paramount to finding interventions to treat this group who are at risk of committing offences.

Featured in

Sky News, Reuters, BBC Newsnight, Today Show, The Guardian, The Mail, The Sun, Al Jazeera, The Telegraph, The Independent, The Times, Sydney Herald, Science Magazine and lots more!

This story has been largely covered by the media, the Today show did an excellent Radio interview with Dr Rahm, the lead investigator on 7th April and Newsnight discussed the research at 10.30pm on the same day recognising the importance of advancing research in this area.  Sky News also went to film in Sweden and did some excellent coverage.

For information on campaign extension see this article in Science Magazine, more information coming soon…

About supporting the research…

You can support this groundbreaking trial by selecting a perk option to the right hand side and pledging your support.  You can also support it by sharing the link using social media.

There is an option to remain anonymous when you pledge.  In addition if you want to pledge and not receive a perk select the amount you would like to pledge via the perk options and email info@walacea.com with subject “no perk”.

IMPORTANT INFORMATION

If you have unwanted sexuality and are concerned, there is help out there

Swedish based phone line PREVENTELL takes calls anonymously and can advice you on how to get further help.

Professional help is offered at Karolinska University Hospital and The Centre for Andrology and Sexual Medicine (CASM),  Support includes doctors, psychologists, social workers, counselling and treatment.

Select your pledge amount

£

CONTINUE
  • 14 Backers

    Thank you: If you feel this is a good cause and have landed on this page please do make a pledge to become a patron of this incredibly important research project (pledges at all perk levels can be made anonymously).

  • 22 Backers

    Thank you postcard: As a token of our appreciation we will send you a thank you postcard from the Karolinska Institute and we will also share the results with you when they are published

  • 7 Backers

    Halfway online seminar: We will invite you to an online seminar when our half way analysis is ready. Questions can be asked prior to and during the seminar.

  • 15 Backers

    Entire analysis online seminar: When the entire analysis is ready. Questions can be asked prior to and during the seminar.

  • 9 Backers

    1 hour open online Q&A session with the scientist: This perk gives you the opportunity to attend an online Q&A session and understand more about the disorder. Depending on demand we may run two separate sessions to accommodate people from different time zones. We will do a call out for questions two weeks before the session and will curate the questions in line with demand (includes all of the above).

  • 2 Backers
    Limit of 60 — 58 remaining

    Seminar at the Karolinska Institute, Sweden: You will be invited to a closed seminar in Stockholm Sweden when the preliminary results have been analyzed, there will be an opportunity to meet the scientists and ask questions as well as propose ideas for future studies.

  • 6 Backers
    Limit of 20 — 14 remaining

    Online tutorials series: The Principle Investigator will run three online tutorials explaining in depth the current view on the cause of paedophilia, and how the different treatment modalities are considered to be effective.

  • Backers
    Limit of 10 — 10 remaining

    One to one 30 minute individual Q&A session: You will have the opportunity to ask any questions you may have about the research and learn directly from Christoffer Rahm, the principle investigator of the study in a one to one setting so you will have his full attention.

  • 1 Backer
    Limit of 10 — 9 remaining

    One to one 90 minute individual Q&A session: As above but more time. This can be split into two sessions if preferred.

  • Backers
    Limit of 10 — 10 remaining

    Funders dinner: For those who pledge £1000 we will organise a dinner in Stockholm followed by some drinks half way through the study. This will be an opportunity to meet the scientists face to face, have an evening out and also make a generous contribution to a very important research area.

  • Backers
    Limit of 10 — 10 remaining

    Funders dinner and accommodation in Stockholm for the night: As above and the team will organise accommodation for you in Stockholm for the evening. The bulk of the money will go to the research, however we will also try to negotiate with some of the top hotels in Stockholm to see if they will offer some of the best rooms for a discounted price.

  • Backers
    Limit of 3 — 3 remaining

    Official Sponsor: As above and we also invite you to be included as an official sponsor in our next publication (as long as you do not represent an organisation that puts the authors of the study in a conflict of interest position). Please email info@walacea.com for further details.

14 Comments

  1. Peter

    I suppose I am one of the target audience. I don’t believe in this treatment. I don’t believe in this treatment. Furthermore I consider your marketing this research as a treatment against paedophilia misleading. If anything it is a treatment against poor impulse control. In a similar fashion it would treat rapists and other sexual predators. I wonder how people would react to you identifying a subset of the population with either genetic, biological or cultural aspects that are prone to raping women and administering this drug with them.

    There is no treatment against paedophilia. Arguably there is a treatment against offending, but I dare say this drug is not it. My primary reason for not offending is the consequences this would have for the child. It are the very feelings that attract me to children that prevents me from acting on those feelings. This drug would also end any possibility for a sexual relation with an adult. For non-exclusive paedophiles that would be a severe drawback and destabilizing factor in their lives. Paedophiles indeed are not necessarily offenders, but that is a choice we have to make. First make the choice not to be offenders, then and only then we can look for help. Removing the stigma on being a paedophile and allow us to moreopen about our attractions would allow us to seek help without fear of reprisal. I believe therapy is far more effective in preventing offending.

    A 2005 study printed in the Journal of the American Academy of Psychology and the Law, found that between zero and 10 percent of sexual offenders who are surgically castrated repeat their crime. That rate of recidivism in surgically castrated offenders is about the same as it for all sex offenders. According to the Department of Justice, 5.3 percent of all sex offenders were rearrested for another sex crime within three years of their release.

    This makes me wonder if this treatment if effective at all. It is high;y unlikely that sexual predators would seek the help of this treatment, and it is also highly doubtful that those that not wish to offend would actually offend without this treatment.

    • Natalie Jonk

      Hello Peter, thank you for taking the time to share your thoughts. The aim of the Priotab research project is not just to focus on drug interventions, it is to investigate a range of therapies that could help people with paedophilia better cope with their feelings. The team need to test one intervention at a time so that they can see the effectiveness as well as drawbacks of each therapy. Science is never perfect and to find answers to complicated and challenging problems takes resources, I’m sorry that you feel this is not the right route, however we see value in this research and hope that others do to.

  2. Ruth

    I’m pretty sure this has been done before (over 20 years ago), using Depo Provera. It was proved to work effectively. The problem has been in legally requiring sex offenders to comply with receiving the injection.

    • Natalie Jonk

      Thank you Ruth, the study is aiming to provide therapies for people with pedophilia who have not sexually offended. There are many non-offending pedophiles who seek help and the aim of the Priotab programme is to develop excellent treatment options for them as and when required.

  3. Lucas Folle

    Also Dr Goode, I think you are extremely biased and off-the-point in your comment.
    This “Priotab is showing us how we can proactively address this complex issue and reduce the risk of sexual abuse for all our children in the future.” is not entirely correct. Yes, there are people that would benefit from chemical castration solutions if they, in conjunction with their doctors, find that they are not able to stop their thoughts from turning into action. Yet, that seems like a small fraction of the pedophile population, imho.

    It would seem to me that solutions as provided by Dunkelfeld are far more effective in terms of helping pedophiles. Yes, the end goal of preventing child abuse is the same but Priotab’s ‘advertising’ itself as a cure seems to imply that all pedophiles should take this shot/pill/whatever and be done with it. So it doesn’t leave room for a person to decide if this is the best way or not for their situation. I understand the Walacea page is supposed to be a ‘business pitch’ in order to attract money to fund raise the research/trials but doing so in this manner sends a bad message.

    • Natalie Jonk

      Hello Lucas,
      Thank you for taking the time to comment on the page, the research does not suggest that drug is a cure, the objective of the study is to test the effectiveness of the drug in people with paedophilia who seek help. The Priotab programme plans to look at both psychological and drug interventions, the clinical trial being funded in this campaign is only a small part of the programme. Currently drug interventions are used off label in this patient group, the plan with this trial is to understand what the dose should be, what side effects to expect and whether it is actually worth using the drug in this patient group or if other interventions are better.
      Natalie

  4. Lucas Folle

    Treat pedophilia? So this is a cure? Or is it another androgen blocker as there are plenty abound? From reading your Walacea page the sense I get is this is just another ‘chemical castration’ solution. So the idea is chemically preventing people without them even having done anything? While there are great projects like Dunkelfeld out there, which you don’t even mention by the way, that successfully help pedophiles not offend (or not re-offend) without any chemical interventions.

    I would highly suggest that your ‘business pitch’ about this drug is skewered and is misleading.

  5. Endymion

    Although I welcome the acknowledgement that most paedophiles will not offend, I am concerned that you are misleading donors and potential donors. The statement that “approximately 50% of those more serious abuses are performed by men with paedophilic disorder” is wildly inaccurate, as studies suggest only around 10% of child sexual abuse is committed by people who are preferentially or exclusively attracted to prepubescent children, with the other 90% being committed by what are termed ‘situational offenders’. This egregious distortion of existing figures therefore exaggerates the role of paedophilic attraction in child sexual abuse.

    Furthermore, you portray the drug as ground-breaking. In terms of mechanism of action, however, it is nothing new – it’s just another antiandrogen, with the only difference being that you intend to administer doses differently. Hence it is also deeply misleading that you state that it’s ‘an acute treatment for paedophilia’. It’s nothing of the sort; it’s a drug that will reduce libido.

    • Natalie Jonk

      Hello, thank you for taking the time to comment. Where have you rad the 50% stat as it is not on the campaign page. Was this something you read in the media? We do not portray the drug ground-breaking in terms of the mechanism of action, we recognise that this is a drug that is known to reduce labido, however conducting a clinical trial on men with paedophilia to test how well they respond to the intervention is an important step that has currently been ignored. The reason Dr Rahm created the Priotab research programme (which looks at a range of interventions to treat paedophilia) was because when he started working at the Karolinska Institute he observed that the treatments being given to people who seek help to control paedophilia had not been tested in a clinical setting. He recognised that there is potential to treat this group in a much more effective manner by conducting clinical trials to better understand the most optimum treatment options.

      • Endymion

        Hi Natalie, and many thanks for your response. I was citing (verbatim) the second sentence of the video above, so it is part of the campaign.

        I presume, then, that the only unique thing about this study is that rather than administering the drug to convicted sex offenders it will be administered to volunteers with paedophilic attraction who feel they are at risk of committing a sexual offence against a child. While I welcome measures that could protect children or reduce distress in paedophiles, I feel that the campaign is deeply misleading, as it is riddled with references to treatments for paedophilia (as is your own reply, incidentally). It isn’t a treatment for paedophilia. Either these references are born of confusion (conflating paedophilia with child molestation) or desire to trick potential donors by tapping into a repository of emotive terms more likely to secure donations.

        • Natalie Jonk

          Hi Alice,
          Thank you for your reply, treatment does not mean cure, it means a medical intervention to control symptoms of a condition. For example I formerly worked in the pharmaceutical industry as a scientific advisor, I worked on a drug called solifencin which controls the symptoms of overactive bladder. It does not cure the condition and if patients discontinue the treatment their symptoms come back. We still called the drug a treatment for overactive bladder. We would never describe it as a cure. In a similar way the Priotab research programme is looking at treatments for paedophilia, they are not looking for a cure. Like you said in your message, the medication is being administered to volunteers with paedophilic attraction. However, these are not sex offenders with paedophilic attraction, these are members of society with paedophilic attraction who have not offended and are seeking help because they are worried about their thoughts and feelings. Hope this clarifies things. We have no desire to trick potential donors, our aim is to make the campaign as clear as possible which is why we have explained the goals of the study and what paedophilia means in simple language and clear sections. Natalie

          • Endymion

            Your response is a red herring. I fully understand the distinction between treatment and cure. When I say the drug is not a treatment for paedophilia, I’m not saying it’s not a cure for paedophilia. I’m saying it’s not a treatment for paedophilia. It is a treatment to reduce sex drive. That has nothing whatsoever to do with treating paedophilia, just as administering the drug to a homosexual male would not be a ‘treatment for homosexuality’.

          • Natalie Jonk

            Hi Alice, it is a treatment to reduce sex drive. In people with paedophilia, their sex drive can lead to distracting and destructive thoughts so reducing sex drive is helping them have more control. It is a complicated and delicate subject area, at the end of the day, we are trying to raise funding for a research project that we believe is taking a brave step to offer better therapy to people with paedophilia to reduce the risk of them offending against children both for the children and also for them as individuals. I’m sorry if you don’t like the way we have structured the campaign and the wording we have used, if you have a better idea or way of formatting what we are trying to do, please email me natalie.jonk@walacea.com with suggestions, I am also happy to talk on the phone. Natalie

  6. Dr Sarah D. Goode

    I am the acting CEO for StopSO (Specialist Treatment Organisation for the Prevention of Sexual Offending), an organisation in the UK committed to offering therapy to anyone worried about their sexual thoughts or behaviours. I am delighted to support this opportunity for a rigorous randomised controlled trial of a medication which can help people with intrusive and distressing sexual urges.
    The most important message of this project is that paedophiles are not necessarily offenders. Many adults sexually attracted to children live successful and law-abiding lives. By researching and offering effective treatment options, Priotab is showing us how we can proactively address this complex issue and reduce the risk of sexual abuse for all our children in the future.

Leave a Reply

  1. Anonymous
    gbp 15.00
  2. Katie Williams
    gbp 7.00
  3. Anonymous
    gbp 12.00
  4. Lena Alnebo
    gbp 3.00
  5. Camilla Wolff-Neukamp
    gbp 50.00
  6. kristian baker
    gbp 3.00
  7. Anonymous
    gbp 50.00
  8. Åsa Nilsonne
    gbp 500.00
  9. Anonymous
    gbp 50.00
  10. Anonymous
    gbp 15.00
  11. Anonymous
    gbp 50.00
  12. Josephine Harden
    gbp 12.00
  13. Ali Syed
    gbp 25.00
  14. Anonymous
    gbp 25.00
  15. Charlotte Hodgson
    gbp 25.00
  16. Anonymous
    gbp 12.00
  17. Pinque Chamberlain
    gbp 3.00
  18. Saria Akhter
    gbp 12.00
  19. Anna Kähler
    gbp 25.00
  20. Lesley Ogilvie
    gbp 15.00
  21. Anonymous
    gbp 25.00
  22. Anonymous
    gbp 25.00
  23. Anonymous
    gbp 15.00
  24. Anonymous
    gbp 25.00
  25. Nick Brennan
    gbp 12.00
  26. Chris Lord
    gbp 15.00
  27. Pablo Estévez Cuntín
    gbp 12.00
  28. Annika Svedlund Vestergren
    gbp 12.00
  29. Jan Westwood
    gbp 50.00
  30. Anonymous
    gbp 25.00
  31. Catriona Smith
    gbp 12.00
  32. Emma New
    gbp 15.00
  33. Anonymous
    gbp 3.00
  34. Stefan Arver
    gbp 3.00
  35. Anonymous
    gbp 25.00
  36. Rob Camp
    gbp 12.00
  37. Julie Newberry
    gbp 25.00
  38. Anonymous
    gbp 3.00
  39. Jörgen Hassler
    gbp 50.00
  40. Anne Thomas
    gbp 3.00
  41. Rachel Porter
    gbp 25.00
  42. Anonymous
    gbp 15.00
  43. Kate McCambridge
    gbp 12.00
  44. Anonymous
    gbp 12.00
  45. Jenny Brandhill
    gbp 3.00
  46. Paul Paulsen
    gbp 12.00
  47. Eva Bodfäldt
    gbp 100.00
  48. Anonymous
    gbp 50.00
  49. Karin Slättne
    gbp 12.00
  50. Irja Björkman
    gbp 6.00
  51. Gunnel Svärdh
    gbp 50.00
  52. Anonymous
    gbp 75.00
  53. Victoria
    gbp 12.00
  54. Andrew Aaron
    gbp 12.00
  55. Anonymous
    gbp 3.00
  56. Christian Panzer
    gbp 25.00
  57. Alex Brooman-White
    gbp 25.00
  58. Moa Mannheimer
    gbp 50.00
  59. Maria Riazzoli
    gbp 12.00
  60. Jonas Bjärehed
    gbp 100.00
  61. Nina Rung
    gbp 12.00
  62. Åsa Landberg
    gbp 25.00
  63. Anonymous
    gbp 3.00
  64. Elisabet Reinholdz -Andersson
    gbp 3.00
  65. David Sondak
    gbp 12.00
  66. Anonymous
    gbp 12.00
  67. Anonymous
    gbp 3.00
  68. Anonymous
    gbp 100.00
  69. Anonymous
    gbp 12.00
  70. Leigh Van Eyck
    gbp 100.00
  71. Anonymous
    gbp 100.00
  72. Michelle Conley
    gbp 12.00
  73. Anonymous
    gbp 12.00
  74. Ainslie Heasman
    gbp 25.00
  75. Anonymous
    gbp 75.00
  76. Anonymous
    gbp 100.00

Terms of Agreement

Member usage

Definitions

Crowd.Science’s Service

Crowd.Science has limited liability

How Campaigns Work

Campaign Owner and Campaign Funder Obligation

Campaign Rewards

Fees Payable to Crowd.Science

Stripe Payment Gateway

Refunds

Communications with Crowd.Science

Tax and legal compliance

Dispute Resolution

Governing Law and Jurisdiction

Third Party Site

Prohibited Use Of Crowd.Science

General Overview

This Campaign has ended. No more pledges can be made.

  • 14 Backers

    Thank you: If you feel this is a good cause and have landed on this page please do make a pledge to become a patron of this incredibly important research project (pledges at all perk levels can be made anonymously).

  • 22 Backers

    Thank you postcard: As a token of our appreciation we will send you a thank you postcard from the Karolinska Institute and we will also share the results with you when they are published

  • 7 Backers

    Halfway online seminar: We will invite you to an online seminar when our half way analysis is ready. Questions can be asked prior to and during the seminar.

  • 15 Backers

    Entire analysis online seminar: When the entire analysis is ready. Questions can be asked prior to and during the seminar.

  • 9 Backers

    1 hour open online Q&A session with the scientist: This perk gives you the opportunity to attend an online Q&A session and understand more about the disorder. Depending on demand we may run two separate sessions to accommodate people from different time zones. We will do a call out for questions two weeks before the session and will curate the questions in line with demand (includes all of the above).

  • 2 Backers
    Limit of 60 — 58 remaining

    Seminar at the Karolinska Institute, Sweden: You will be invited to a closed seminar in Stockholm Sweden when the preliminary results have been analyzed, there will be an opportunity to meet the scientists and ask questions as well as propose ideas for future studies.

  • 6 Backers
    Limit of 20 — 14 remaining

    Online tutorials series: The Principle Investigator will run three online tutorials explaining in depth the current view on the cause of paedophilia, and how the different treatment modalities are considered to be effective.

  • Backers
    Limit of 10 — 10 remaining

    One to one 30 minute individual Q&A session: You will have the opportunity to ask any questions you may have about the research and learn directly from Christoffer Rahm, the principle investigator of the study in a one to one setting so you will have his full attention.

  • 1 Backer
    Limit of 10 — 9 remaining

    One to one 90 minute individual Q&A session: As above but more time. This can be split into two sessions if preferred.

  • Backers
    Limit of 10 — 10 remaining

    Funders dinner: For those who pledge £1000 we will organise a dinner in Stockholm followed by some drinks half way through the study. This will be an opportunity to meet the scientists face to face, have an evening out and also make a generous contribution to a very important research area.

  • Backers
    Limit of 10 — 10 remaining

    Funders dinner and accommodation in Stockholm for the night: As above and the team will organise accommodation for you in Stockholm for the evening. The bulk of the money will go to the research, however we will also try to negotiate with some of the top hotels in Stockholm to see if they will offer some of the best rooms for a discounted price.

  • Backers
    Limit of 3 — 3 remaining

    Official Sponsor: As above and we also invite you to be included as an official sponsor in our next publication (as long as you do not represent an organisation that puts the authors of the study in a conflict of interest position). Please email info@walacea.com for further details.